Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$32.94 - $56.62 $8.36 Million - $14.4 Million
-253,670 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$44.47 - $81.38 $11.3 Million - $20.6 Million
253,670 New
253,670 $13.6 Million

Others Institutions Holding VCYT

About VERACYTE, INC.


  • Ticker VCYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,575,904
  • Market Cap $1.54B
  • Description
  • Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...
More about VCYT
Track This Portfolio

Track Graticule Asia Macro Advisors LLC Portfolio

Follow Graticule Asia Macro Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Graticule Asia Macro Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Graticule Asia Macro Advisors LLC with notifications on news.